Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Increasing national mastectomy rates for the treatment of early stage breast cancer.

Mahmood U, Hanlon AL, Koshy M, Buras R, Chumsri S, Tkaczuk KH, Cheston SB, Regine WF, Feigenberg SJ.

Ann Surg Oncol. 2013 May;20(5):1436-43. doi: 10.1245/s10434-012-2732-5. Epub 2012 Nov 8.

PMID:
23135312
2.

[Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].

Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH.

Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):520-5. Chinese.

PMID:
21029696
3.

Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.

Pesce C, Liederbach E, Wang C, Lapin B, Winchester DJ, Yao K.

Ann Surg Oncol. 2014 Oct;21(10):3231-9. doi: 10.1245/s10434-014-3956-3. Epub 2014 Aug 1.

PMID:
25081341
4.

Axillary surgery among estrogen receptor positive women 70 years of age or older with clinical stage I breast cancer, 2004-2010: a report from the National Cancer Data Base.

Pesce C, Czechura T, Winchester DJ, Huo D, Winchester DP, Yao K.

Ann Surg Oncol. 2013 Oct;20(10):3259-65. doi: 10.1245/s10434-013-3153-9. Epub 2013 Aug 22.

PMID:
23975297
5.

Nationwide trends in mastectomy for early-stage breast cancer.

Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA.

JAMA Surg. 2015 Jan;150(1):9-16. doi: 10.1001/jamasurg.2014.2895.

PMID:
25408966
6.

Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.

Cao AY, He M, Liu ZB, Di GH, Wu J, Lu JS, Liu GY, Shen ZZ, Shao ZM.

Ann Surg Oncol. 2012 Sep;19(9):3019-27. doi: 10.1245/s10434-012-2322-6. Epub 2012 Mar 27.

PMID:
22451233
7.

Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.

Grann VR, Troxel AB, Zojwalla NJ, Jacobson JS, Hershman D, Neugut AI.

Cancer. 2005 Jun 1;103(11):2241-51.

8.
9.

Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database.

Garcia-Etienne CA, Tomatis M, Heil J, Friedrichs K, Kreienberg R, Denk A, Kiechle M, Lorenz-Salehi F, Kimmig R, Emons G, Danaei M, Heyl V, Heindrichs U, Rageth CJ, Janni W, Marotti L, del Turco MR, Ponti A; eusomaDB Working Group..

Eur J Cancer. 2012 Sep;48(13):1947-56. doi: 10.1016/j.ejca.2012.03.008. Epub 2012 Apr 4.

PMID:
22483323
10.

Increasing mastectomy rates among all age groups for early stage breast cancer: a 10-year study of surgical choice.

Dragun AE, Huang B, Tucker TC, Spanos WJ.

Breast J. 2012 Jul-Aug;18(4):318-25. doi: 10.1111/j.1524-4741.2012.01245.x. Epub 2012 May 21.

PMID:
22607016
11.

[Clinicopathologic analysis of the nipple-areolar complex occult involvement in early stage breast carcinoma].

Wang SY, Peng DF, Cai ZG, Zhang RZ, Yao TJ, Zhang H, Yang M, Dong HM.

Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):203-6. Chinese.

PMID:
18756937
12.

Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base.

Pesce CE, Liederbach E, Czechura T, Winchester DJ, Yao K.

J Am Coll Surg. 2014 Jul;219(1):19-28. doi: 10.1016/j.jamcollsurg.2014.03.043. Epub 2014 Apr 1.

PMID:
24862886
13.
14.

Patterns of care for immediate and early delayed breast reconstruction following mastectomy.

Joslyn SA.

Plast Reconstr Surg. 2005 Apr 15;115(5):1289-96.

PMID:
15809588
15.

Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.

Jatoi I, Parsons HM.

Breast Cancer Res Treat. 2014 Nov;148(2):389-96. doi: 10.1007/s10549-014-3160-y. Epub 2014 Oct 10.

16.

Surgical Management of Breast Cancer in 2010-2011 SEER Registries by Hormone and HER2 Receptor Status.

Lizarraga I, Schroeder MC, Weigel RJ, Thomas A.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S566-72. doi: 10.1245/s10434-015-4591-3. Epub 2015 May 9.

PMID:
25956579
17.

Predictors of early distant metastasis in women with breast cancer.

Rosa Mendoza ES, Moreno E, Caguioa PB.

J Cancer Res Clin Oncol. 2013 Apr;139(4):645-52. doi: 10.1007/s00432-012-1367-z. Epub 2013 Jan 3.

PMID:
23283528
18.

[Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].

Zhang P, Xu BH, Ma F, Li Q, Yuan P, Wang JY, Zhang P.

Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):381-4. Chinese.

PMID:
21875471
19.

Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.

Milgrom S, Cody H, Tan L, Morrow M, Pesce C, Setton J, Rogers K, Arnold B, Eaton A, Catalano J, McCormick B, Powell S, Ho A.

Ann Surg Oncol. 2012 Nov;19(12):3762-70. doi: 10.1245/s10434-012-2386-3. Epub 2012 May 11.

PMID:
22576064
20.

Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.

Fields EC, DeWitt P, Fisher CM, Rabinovitch R.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):747-52. doi: 10.1016/j.ijrobp.2013.07.016.

PMID:
24138917

Supplemental Content

Support Center